InvestorsHub Logo
Followers 32
Posts 12718
Boards Moderated 0
Alias Born 08/29/2012

Re: None

Saturday, 03/25/2023 10:41:03 PM

Saturday, March 25, 2023 10:41:03 PM

Post# of 402388
The top 10 drugs losing US exclusivity in 2023

https://www.fiercepharma.com/special-reports/top-10-drugs-losing-us-exclusivity-2023

March 13, 2023

VERY long article if you want to read the whole thing. There might be a stupid advertisement that takes up the whole screen when you click on the link above. Just scroll down past it for the article.

For each drug, the article lists the company who currently makes it, the most recent sales figures, and the expected month for generics entry.

1 - Humira (adalimumab)
2 - Stelara (ustekinumab)
3 - Vyvanse (lisdexamfetamine)
4 - Aubagio (teriflunomide)
5 - Actemra (tocilizumab)
6 - Xyrem (sodium oxybate)
7 - Symbicort (budesonide/formoterol)
8 - Lexiscan (regadenoson)
9 - Gattex (teduglutide)
10 - Trokendi XR (topiramate)


------------------------------------------------------------------------------------------------------------------------------------------

MAKE ELITE GREAT AGAIN!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News